¥12.43 ($1.85)

+0.25 (+2.05%)

SHH · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 33 · ¥12.0B mcap · 569M float · 3.89% daily turnover

Revenue

$9.4B +20.3% ▲

5Y CAGR: +5.9%

Gross Profit

$3.8B +57.6% ▲

5Y CAGR: +6.4%

Operating Income

$1.2B +221.7% ▲

5Y CAGR: +24.5%

Net Income

$1.2B +170.1% ▲

5Y CAGR: +27.6%

EPS (Diluted)

$1.21 +168.9% ▲

5Y CAGR: +27.6%

EBITDA

$1.9B +169.6% ▲

5Y CAGR: +20.3%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$7.3B	$9.1B	$8.1B	$7.8B	$9.4B
YoY Growth	+4.0%	+24.6%	-11.1%	-4.0%	+20.3%
Cost of Revenue	$4.4B	$5.5B	$5.4B	$5.4B	$5.6B
Gross Profit	$2.9B	$3.6B	$2.7B	$2.4B	$3.8B
Gross Margin	39.8%	39.4%	33.0%	30.8%	40.4%
R&D Expenses	$546M	$807M	$809M	$860M	$749M
SG&A Expenses	$1.5B	$1.5B	$1.3B	$1.5B	$1.7B
Operating Expenses	$2.0B	$2.4B	$2.2B	$2.0B	$2.6B
Operating Income	$883M	$1.2B	$505M	$380M	$1.2B
Operating Margin	12.0%	12.9%	6.2%	4.9%	13.0%
Interest Expense	$51M	$44M	$42M	$28M	$35M
Income Before Tax	$851M	$1.2B	$491M	$363M	$1.2B
Tax Expense	$191M	$269M	$129M	$86M	$192M
Net Income	$717M	$1.0B	$540M	$430M	$1.2B
Net Margin	9.8%	11.5%	6.6%	5.5%	12.4%
EPS (Diluted)	$0.75	$1.09	$0.56	$0.45	$1.21
EBITDA	$1.3B	$1.7B	$1.2B	$706M	$1.9B
Shares Outstanding	958M	958M	959M	955M	959M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$2.7B	$2.3B	$2.3B	$2.1B	$2.4B	$2.2B	$2.2B	$2.2B
Cost of Revenue	$1.3B	$1.3B	$1.3B	$1.4B	$1.6B	$1.6B	$1.4B	$1.4B
Gross Profit	$1.4B	$936M	$979M	$660M	$789M	$568M	$768M	$832M
Gross Margin	50.5%	41.4%	43.4%	31.9%	33.3%	26.0%	35.1%	37.9%
R&D Expenses	$169M	$202M	$177M	$136M	$160M	$107M	$94M	$0
SG&A Expenses	$478M	$451M	$342M	$316M	$344M	-$16M	$336M	$347M
Operating Expenses	$770M	$649M	$525M	$352M	$545M	$654M	$462M	$539M
Operating Income	$596M	$286M	$454M	$308M	$244M	-$85M	$306M	$293M
Operating Margin	22.0%	12.6%	20.1%	14.9%	10.3%	-3.9%	14.0%	13.4%
Interest Expense	$6M	$5M	$6M	$6M	$6M	$6M	$5M	$6M
Income Before Tax	$596M	$281M	$454M	$305M	$287M	-$95M	$306M	$313M
Tax Expense	$93M	$20M	$69M	$66M	$45M	$12M	$48M	$56M
Net Income	$534M	$311M	$409M	$264M	$260M	-$60M	$287M	$319M
Net Margin	19.7%	13.7%	18.1%	12.8%	11.0%	-2.7%	13.1%	14.5%
EPS (Diluted)	$0.56	$0.33	$0.43	$0.28	$0.27	$-0.06	$0.30	$0.33
EBITDA	$885M	$355M	$654M	$370M	$295M	$118M	$311M	$293M
Shares Outstanding	962M	955M	951M	960M	948M	951M	957M	962M

600216.SS SHH